Clinical Trial Detail

NCT ID NCT03682289
Title Phase II Trial of AZD6738 Alone and in Combination With Olaparib
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

clear cell renal cell carcinoma

transitional cell carcinoma

pancreatic ductal adenocarcinoma

Advanced Solid Tumor

Therapies

AZD6738 + Olaparib

Olaparib

Age Groups: adult senior

No variant requirements are available.